The University of Maryland Marlene and Stewart Greenebaum Cancer Center has established a new research program focused on issues of cancer epidemiology, prevention and disparities to be led jointly by Dr. Joanne Dorgan, Professor of Epidemiology and Public Health at the University of Maryland Baltimore and Dr. Cheryl Holt, Associate Professor, Department of Behavioral and Community Health, University of Maryland College Park School of Public Health. The new Population Science Program is the result of a multi-year strategic effort led by Dr. William Blattner, Associate Director for Population Science at the Cancer Center and Professor of Medicine and Epidemiology and Public Health. The new program will enhance the Cancer Center’s efforts in population science and epidemiology and will consolidate efforts on the University of Maryland Baltimore and College Park campuses. The new program will bring together investigators with a range of expertise including cancer disparities, tobacco control, molecular epidemiology, genetics and genomics of pain, as well as other disciplines.
The program will include investigators from the School of Medicine and School of Nursing on the UMB campus as well as investigators from the School of Public Health in College Park. The program came about as part of a collaborative strategic planning effort led by Dr. Blattner and Dr. Mei-Ling Ting Lee, Professor, Department of Epidemiology and Biostatistics and Director, Biostatistics and Risk Assessment, University of Maryland College Park School of Public Health. Dr. Blattner and Dr. Lee established the University of Maryland Cancer Epidemiology Alliance (UMCEA) in 2013, supported in part by seed funds from the State of Maryland Cigarette Restitution Fund Program. The alliance was also a focus to recruit new investigators to this combined effort culminating in the arrival of Dr. Joanne Dorgan, an internationally recognized investigator in the area of molecular epidemiology of breast and prostate cancer. Dr. Dorgan was recruited from the Fox Chase Cancer Center in Philadelphia and joined the faculty this past summer.
The new research program will push the Greenebaum Cancer Center forward in its efforts to achieve NCI Comprehensive Cancer Center designation when the Cancer Center Support Gant (P30) is renewed in 2016. To qualify as a comprehensive cancer center, a strong interdisciplinary research effort in population science is required.